Table 4. Clinical relevance assessment strength and endurance shoulder, and the DASH score: Baseline2 vs 12W.
| Variable | MD | IC 95% FOR MD | Pooled SD | MID * 0.2 | MID * 0.5 | Effect Size | Clinical Relevance | |
|---|---|---|---|---|---|---|---|---|
| LL | UL | |||||||
| DASH score | -9.12 | -24.59 | 6.36 | 20.09 | 4,018 | 10,045 | -0.44 | PCR |
| IR Strength DS | 1.05 | -3.57 | 5.66 | 6.17 | 1,234 | 3,085 | 0.17 | NCR |
| IR Strength NDS | 0.91 | -3.55 | 5.37 | 5.96 | 1,192 | 2.98 | 0.15 | NCR |
| ER Strength DS | 2.47 | -1.04 | 5.98 | 4.7 | 0.94 | 2.35 | 0.53 | CR |
| ER Strength NDS | 3.37 | -0.99 | 7.73 | 5.83 | 1,166 | 2,915 | 0.58 | CR |
| Endurance Flexion DS | 102.32 | -22.67 | 227.3 | 167.1 | 33.42 | 83.55 | 0.61 | CR |
| Endurance Flexion NDS | 58.89 | -66.63 | 184.4 | 148.6 | 29.72 | 74.3 | 0.35 | NCR |
| Endurance Abduction DS | 62.83 | -25.16 | 150.82 | 117.64 | 23,528 | 58.82 | 0.53 | NCR |
| Endurance Abduction NDS | 50.07 | -47.44 | 147.59 | 130.37 | 26,074 | 65,185 | 0.38 | NCR |
MD, mean differences; IC 95% = Limits with 95% of reliability; LL, lower limit; UL, upper limit; SD, standard deviation;
MID, minimal importance difference; NCR, not clinically relevant; PCR, potentially clinically relevant; CR, clinically relevant; DS, dominant side; NDS, non-dominant side.